986 related articles for article (PubMed ID: 26646248)
21. New in vitro model evaluating antiseptics' efficacy in biofilm-associated Staphylococcus aureus prosthetic vascular graft infection.
Staneviciute E; Na'amnih W; Kavaliauskas P; Prakapaite R; Ridziauskas M; Kevlicius L; Kirkliauskiene A; Zabulis V; Urboniene J; Triponis V
J Med Microbiol; 2019 Mar; 68(3):432-439. PubMed ID: 30735113
[TBL] [Abstract][Full Text] [Related]
22. Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
Drago L; De Vecchi E; Mattina R; Romanò CL
Int J Artif Organs; 2013 Jan; 36(1):39-46. PubMed ID: 23280076
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
25. The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection.
Ma D; Mandell JB; Donegan NP; Cheung AL; Ma W; Rothenberger S; Shanks RMQ; Richardson AR; Urish KL
mBio; 2019 Nov; 10(6):. PubMed ID: 31772059
[No Abstract] [Full Text] [Related]
26. Impact of nanosystems in Staphylococcus aureus biofilms treatment.
Pinto RM; Lopes-de-Campos D; Martins MCL; Van Dijck P; Nunes C; Reis S
FEMS Microbiol Rev; 2019 Nov; 43(6):622-641. PubMed ID: 31420962
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus.
Fujimura S; Sato T; Kikuchi T; Zaini J; Gomi K; Watanabe A
J Orthop Sci; 2009 Sep; 14(5):658-61. PubMed ID: 19802681
[TBL] [Abstract][Full Text] [Related]
28. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
Hogan S; O'Gara JP; O'Neill E
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
[TBL] [Abstract][Full Text] [Related]
29. Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies.
Raafat D; Otto M; Reppschläger K; Iqbal J; Holtfreter S
Trends Microbiol; 2019 Apr; 27(4):303-322. PubMed ID: 30665698
[TBL] [Abstract][Full Text] [Related]
30. Dispersal of Bap-mediated Staphylococcus aureus biofilm by proteinase K.
Kumar Shukla S; Rao TS
J Antibiot (Tokyo); 2013 Feb; 66(2):55-60. PubMed ID: 23149515
[TBL] [Abstract][Full Text] [Related]
31. Vision for medicine: Staphylococcus aureus biofilm war and unlocking key's for anti-biofilm drug development.
Mohammed YHE; Manukumar HM; Rakesh KP; Karthik CS; Mallu P; Qin HL
Microb Pathog; 2018 Oct; 123():339-347. PubMed ID: 30057355
[TBL] [Abstract][Full Text] [Related]
32. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
33. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.
Chan C; Hardin TC; Smart JI
Future Microbiol; 2015; 10(8):1325-38. PubMed ID: 26083676
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
35. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
36. Influence of prophylactic antibiotics on tissue integration versus bacterial colonization on poly(methyl methacrylate).
Subbiahdoss G; Aleyt T; Kuijer R; Busscher HJ; van der Mei HC
Int J Artif Organs; 2012 Oct; 35(10):840-6. PubMed ID: 23138708
[TBL] [Abstract][Full Text] [Related]
37. Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.
Chung PY; Toh YS
Pathog Dis; 2014 Apr; 70(3):231-9. PubMed ID: 24453168
[TBL] [Abstract][Full Text] [Related]
38. Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
Boudjemaa R; Steenkeste K; Jacqueline C; Briandet R; Caillon J; Boutoille D; Le Mabecque V; Tattevin P; Fontaine-Aupart MP; Revest M
J Antimicrob Chemother; 2018 Sep; 73(9):2418-2421. PubMed ID: 29901764
[TBL] [Abstract][Full Text] [Related]
39. Bacterial biofilm formation on a human cochlear implant.
Pawlowski KS; Wawro D; Roland PS
Otol Neurotol; 2005 Sep; 26(5):972-5. PubMed ID: 16151345
[TBL] [Abstract][Full Text] [Related]
40. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation.
Park JH; Lee JH; Kim CJ; Lee JC; Cho MH; Lee J
Biotechnol Lett; 2012 Apr; 34(4):655-61. PubMed ID: 22160331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
